Summit Therapeutics (SMMT) Current Deferred Revenue (2016 - 2022)
Summit Therapeutics' Current Deferred Revenue was $3.23 million in Q2 2022, down 54.7% from $7.14 million a year earlier and down 36.6% from the prior quarter.
Powered by 
Analysis
Summit Therapeutics (SMMT) Current Deferred Revenue (2016 - 2022) Analysis & Trends
At the end of FY2021, Current Deferred Revenue at Summit Therapeutics came in at $7.94 million, down 5.1% from FY2020.
- Current Deferred Revenue shows a three-year compound annual growth rate of -24.6% (FY2018 to FY2021).
- In earlier years, Current Deferred Revenue was $8.37 million in FY2020 (+220.1%), $2.62 million in FY2019 and $18.54 million in FY2018.
- The Q2 2022 figure marks the lowest quarterly Current Deferred Revenue since Q4 2019.
- Compared with a year earlier, Current Deferred Revenue has declined for three straight quarters, with growth averaging 26.9% over the last five quarters.
- Per Business Quant data, SMMT's Current Deferred Revenue in the three quarters before Q2 2022 was $5.1 million (Q1 2022), $7.94 million (Q4 2021) and $7.51 million (Q3 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Summit Therapeutics | 14.26 Bn | 11.63 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 3.23 Mn |
| Mar 31, 2022 | 5.10 Mn |
| Dec 31, 2021 | 7.94 Mn |
| Sep 30, 2021 | 7.51 Mn |
| Jun 30, 2021 | 7.14 Mn |
| Mar 31, 2021 | 7.42 Mn |
| Dec 31, 2020 | 8.37 Mn |
| Sep 30, 2020 | 7.11 Mn |
| Mar 31, 2020 | -1.03 Mn |
| Dec 31, 2019 | 2.62 Mn |
| Oct 31, 2019 | -589,608.98 |
| Jul 31, 2019 | -707,805.29 |
| Jan 31, 2019 | -1.09 Mn |
| Oct 31, 2018 | -1.21 Mn |
| Jul 31, 2018 | -1.42 Mn |
| Apr 30, 2018 | -35.23 Mn |
| Dec 23, 2017 | 745,290.07 |
| Oct 31, 2017 | -24.48 Mn |
| Jul 31, 2017 | -26.60 Mn |
| Apr 30, 2017 | -28.32 Mn |
API Access
Summit Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();